Anodyne| Metfendrazine | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 164.25 g/mol [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H16N2 [1] |
| IUPAC name | 1-methyl-1-(1-phenylpropan-2-yl)hydrazine [1] |
| SMILES | CC(CC1=CC=CC=C1)N(C)N [1] |
| InChI | InChI=1S/C10H16N2/c1-9(12(2)11)8-10-6-4-3-5-7-10/h3-7,9H,8,11H2,1-2H3 [1] |
| InChIKey | MCBDVQRENMFNSU-UHFFFAOYSA-N [1] |
Metfendrazine
Metfendrazine (also known as MO-482, A 17767, 1-Methyl-1-(1-methyl-2-phenylethyl)hydrazine, Hydrazine, 1-methyl-1-(α-methylphenethyl)-, 1-Methyl-1-(α-methylphenethyl)hydrazine, orb1699965, Wln: zn1&y1&1r, CS-0084465, Hydrazine, 1-methyl-1-(1-methyl-2-phenylethyl)- or Q6823531) is a monoamine oxidase inhibitor substance of the amphetamine class.
Chemistry
Stereochemistry []
Metfendrazine is a achiral mixture of the optical stereoisomers
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 19516, Metfendrazine. Accessed July 20, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/19516
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metfendrazine. UNII: A52QTC656T. Global Substance Registration System. Accessed July 20, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/A52QTC656T